Tianjin Development Flags Sharp Profit Drop at Lisheng Pharmaceutical for H1 2026Tip Ranks·Jul 14 at 05:37 PM00882+1.90%002393+0.92%
Tianjin Development affiliate Lisheng Pharmaceutical invests RMB 180 million in Industrial Bank wealth productsPUBT·Jun 25 at 05:32 AM601166-1.05%00882+1.90%
UBS lowers the target price for SINO BIOPHARM to 11 yuan, rating it as "Buy"AASTOCKS·Mar 29 at 11:28 PM516930+1.04%159892+0.42%
Buying Platforms, Selling Pipelines: Deconstructing the Innovation Logic of SINO BIOPHARMWallstreetcn·Mar 27 at 12:24 AM516820+0.58%159929+0.68%
Tianjin Development's subsidiary Lishengpharma A's annual net profit increased by 125.6% to 416 million RMB, with a dividend of 60 cents RMBAASTOCKS·Mar 24 at 07:25 PM159892+0.42%520880-0.46%
Tianjin Development’s Pharma Unit Lisheng Posts Profit Surge and Proposes DividendTip Ranks·Mar 24 at 05:43 PM002393+0.92%00882+1.90%
Tianjin Development’s Lisheng Pharma Unit Posts Strong 2025 Preliminary Profit SurgeTip Ranks·Mar 9 at 05:37 PM513700+0.35%516930+1.04%
Tianjin Development's subsidiary invests RMB 85 million to subscribe to wealth management productsAASTOCKS·Dec 28, 2025 at 07:39 PM601166-1.05%00882+1.90%
Lishengpharma: Company executives plan to reduce their holdings by no more than 11,200 shares of the company36Kr·Nov 20, 2025 at 04:36 AM002393+0.92%
Lishengpharma released its performance for the first three quarters, with a net profit attributable to the parent company of 371 million yuan, a year-on-year increase of 119.05%Zhitong·Oct 23, 2025 at 03:01 AM002393+0.92%
Tianjin Development's subsidiary Lishengpharma plans to invest 174 million yuan to participate in the establishment of a fundZhitong·Sep 10, 2025 at 06:40 AM002393+0.92%
Lishengpharma: Potassium Chloride Sustained-Release Tablets have passed the market approval applicationZhitong·Aug 26, 2025 at 03:03 AM002393+0.92%
Tianjin Development: Lishengpharma's mid-term net profit attributable to the parent company is 343 million yuan, an increase of 235.04% year-on-yearZhitong·Aug 21, 2025 at 11:28 PM002393+0.92%
